Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome |
| |
Authors: | Antonio Galán Brotons Joaquín Borrás-Blasco J. Dolores Rosique Robles José María Vicent Verge Elvira Casterá |
| |
Affiliation: | (1) Oncology Service, Hospital de Sagunto Universidad de Valencia, Valencia, Spain;(2) Pharmacy Service, Hospital de Sagunto, Avda. Ramón y Cajal, s/n, ES-46520 Sagunto, Valencia, Spain |
| |
Abstract: | A woman diagnosed of a renal cell carcinoma in 1989 had a metastatic kidney cancer localised in subcutaneous nodules, gut and lung in 2007. Sorafenib treatment was initiated a 400 mg orally twice a day. The patient developed generalised erythematous skin eruptions and two weeks later a widespread erythematous maculopapular eruption located exclusively on the legs and arms, along with an objective response. The most likely cause of the generalised erythematous skin eruptions was considered to be sorafenib because of the close temporal relationship between exposure to the drug and onset of symptoms. Furthermore, a relationship between sorafenib skin toxicity and treatment efficacy was observed. This therapeutic efficacy of EGFR inhibitors and cutaneous side effects should be better assessed in large cohorts or trials to determine whether the skin toxicity of patients can be linked to an objective antitumour response. |
| |
Keywords: | Sorafenib Cutaneous toxicity Adverse drug reaction Oral multikinase inhibitor Renal cell carcinoma |
本文献已被 SpringerLink 等数据库收录! |
|